A prospective student pilot, age 16, has raised a medical certification question that touches on two disclosure areas frequently encountered by FAA Aviation Medical Examiners (AMEs): past psychiatric medication use and prior surgery. The applicant took Fluoxetine (an SSRI commonly marketed as Prozac) for anxiety at approximately age 10, discontinued it more than five years ago, and underwent a surgical procedure in 2021 to address a non-cancerous bone infection in the foot. The applicant is pursuing a Third Class medical certificate, the least restrictive class required for student pilot operations and private pilot privileges under 14 CFR Part 67. Both items must be disclosed on FAA Form 8500-8, which asks applicants to report all medical history truthfully — omissions or falsifications constitute a federal offense under 18 U.S.C. § 1001 and can result in permanent certificate denial or revocation.
Regarding the Fluoxetine history, the FAA's concern in psychiatric medication cases centers primarily on the underlying condition rather than the medication itself. In 2010, the FAA implemented a Special Issuance pathway allowing pilots currently taking certain SSRIs — including Fluoxetine, Sertraline, Citalopram, and Escitalopram — to obtain medical certificates under controlled circumstances. For an applicant who has been off the medication for over five years with no recurring symptoms, the threshold concern is substantially lower. The AME will assess whether the underlying anxiety condition was situational or developmental in nature, whether it has fully resolved, and whether there is any ongoing functional impairment. Childhood anxiety treated briefly and discontinued without relapse is generally viewed as a favorable history, though the AME or the FAA's Aerospace Medical Certification Division (AMCD) in Oklahoma City may request records from the treating physician confirming the course and resolution of treatment.
The foot surgery presents a more straightforward path to certification. Orthopedic procedures for resolved infections — likely osteomyelitis or a related bone pathology — that occurred years prior, with documented full recovery and no functional limitation, are routinely cleared by AMEs without deferral to AMCD. The applicant will be expected to provide operative reports and any post-surgical follow-up documentation. An AME will assess range of motion, residual symptoms, and whether the condition could recur or impair flight control operation. Absent ongoing complications, this history is unlikely to generate significant regulatory friction during the certification process.
The broader takeaway for pilots and operators who advise aspiring aviators is the critical importance of pre-exam consultation with a qualified AME before submitting Form 8500-8. Many AMEs offer informal consultations where an applicant can discuss medical history in advance, understand likely outcomes, and avoid the uncertainty of a deferred certification. Organizations such as AOPA's Medical Certification Services and the Foundation for Aviation Safety provide free or low-cost guidance to pilots navigating complex medical histories. The FAA has made incremental progress in recent years toward a more nuanced, evidence-based approach to psychiatric history — the SSRI Special Issuance program being one example — but the system still places the disclosure burden entirely on the applicant, making informed preparation essential. For young pilots entering the system with complex histories, early and transparent engagement with an experienced AME remains the single most effective risk-mitigation strategy.